Back to series
#ESC2021 Hotline: Results from the FIGARO-DKD trial Effect of finerenone on cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
MedShr Editor
MedShr

#ESC2021 Hotline: Results from the FIGARO-DKD trial Effect of finerenone on cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes

MedShr Editor

#ESC2021 Hotline Presentation

Sign up to start learning
,